AKT1 and amyotrophic lateral sclerosis: Thus, the PI3K/AKT/FoxO signaling pathway is likely a key mechanism driving the synergistic effects of VPA and ALA combination therapy in ALS, which will be further investigated in our subsequent mechanistic validation.